Moreno M, Aristu J, Ramos L I, Arbea L, López-Picazo J M, Cambeiro M, Martínez-Monge R
Department of Oncology, Clínica Universitaria, University of Navarra, Pamplona, Spain.
Clin Transl Oncol. 2007 Sep;9(9):596-602. doi: 10.1007/s12094-007-0109-1.
Radiation pneumonitis (RP) is a restricting complication of non-small-cell lung cancer irradiation. Three-dimensional conformal radiotherapy (3D-CRT) represents an advance because exposure of normal tissues is minimised. This study tries to identify prognostic factors associated with severe RP.
Eighty patients with stage IIIA (20%) and IIIB (80%) NSCLC treated with cisplatin- based induction chemotherapy followed by concurrent chemotherapy and hyperfractionated 3D-CRT (median dose: 72.4 Gy, range: 54.1-85.9) were retrospectively evaluated. Acute and late RP were scored using RTOG glossary. Potential predictive factors evaluated included clinical, therapeutic and dosimetric factors. The lungs were defined as a whole organ. Univariate and multivariate analyses were performed.
Early and late RP grade>or=3 were observed in two patients (2%) and 10 patients (12%), respectively. Five patients (6%) died of pulmonary toxicity, 3 of whom had pre-existing chronic obstructive pulmonary disease (COPD). Median time to occurrence of late RP was 4.5 months (range: 3-8). Multivariate analysis showed that COPD (OR=10.1, p=0.01) and NTCPkwa>30% (OR=10.5, p=0.007) were independently associated with late grade>or=3 RP. Incidence of RP>or=3 grade for patients with COPD and/or NTCPkwa>30% was 25% vs. 4% for patients without COPD and NTCPkwa<30% (p=0.01). Risk of severe RP was higher for patients with COPD and/or NTCPkwa>30% (OR=7.3; CI 95%=1.4-37.3, p=0.016).
COPD and NTCP are predictive of severe RP. Careful medical evaluation and meticulous treatment planning are of paramount importance to decrease the incidence of severe RP.
放射性肺炎(RP)是影响非小细胞肺癌放疗的一种限制性并发症。三维适形放疗(3D-CRT)是一种进步,因为它可将正常组织的受照剂量降至最低。本研究旨在确定与严重放射性肺炎相关的预后因素。
回顾性评估了80例IIIA期(20%)和IIIB期(80%)非小细胞肺癌患者,这些患者接受了以顺铂为基础的诱导化疗,随后进行同步化疗和超分割3D-CRT(中位剂量:72.4 Gy,范围:54.1-85.9)。使用美国放射肿瘤学会(RTOG)术语对急性和晚期放射性肺炎进行评分。评估的潜在预测因素包括临床、治疗和剂量学因素。将肺视为一个整体器官。进行单因素和多因素分析。
分别有2例患者(2%)和10例患者(12%)出现早期和晚期RP≥3级。5例患者(6%)死于肺部毒性,其中3例有慢性阻塞性肺疾病(COPD)病史。晚期RP发生的中位时间为4.5个月(范围:3-8个月)。多因素分析显示,COPD(比值比[OR]=10.1,p=0.01)和正常组织并发症概率(NTCP)kwa>30%(OR=10.5,p=0.007)与晚期≥3级RP独立相关。有COPD和/或NTCP kwa>30%的患者RP≥3级的发生率为25%,而无COPD且NTCP kwa<30%的患者为4%(p=0.01)。有COPD和/或NTCP kwa>30%的患者发生严重RP的风险更高(OR=7.3;95%置信区间[CI]=1.4-37.3,p=0.016)。
COPD和NTCP可预测严重RP。仔细的医学评估和精心的治疗计划对于降低严重RP的发生率至关重要。